Volume 23 Issue 2
Feb.  2025
Turn off MathJax
Article Contents
BAI Wenhua, LI Xiangpei, LIU Juan, LIU Yan, JIANG Zhen. Correlations between miR-223/ mTOR/ S6K pathway and the activity of rheumatoid arthritis and antibody levels[J]. Chinese Journal of General Practice, 2025, 23(2): 207-210. doi: 10.16766/j.cnki.issn.1674-4152.003868
Citation: BAI Wenhua, LI Xiangpei, LIU Juan, LIU Yan, JIANG Zhen. Correlations between miR-223/ mTOR/ S6K pathway and the activity of rheumatoid arthritis and antibody levels[J]. Chinese Journal of General Practice, 2025, 23(2): 207-210. doi: 10.16766/j.cnki.issn.1674-4152.003868

Correlations between miR-223/ mTOR/ S6K pathway and the activity of rheumatoid arthritis and antibody levels

doi: 10.16766/j.cnki.issn.1674-4152.003868
Funds:

 BRA2020226

  • Received Date: 2024-05-12
    Available Online: 2025-03-27
  •   Objective  To investigate the expression levels of miR-223 and the mTOR / S6K pathway in synovial tissues of rheumatoid arthritis (RA) and their correlation with disease activity and antibody levels.  Methods  A total of 17 RA patients who were hospitalized in the Department of Rheumatology and Immunology of Huaian First People' s Hospital from January 2016 to December 2017 with moderate to severe disease RA were selected, along with 9 patients hospitalized for knee osteoarthritis (OA) surgery as controls. The synovial tissue from the knees of RA patients was obtained under the guidance of ultrasound, while tissue from OA patients were obtained by orthopedic surgeons. The expression levels of mTOR, S6K, RPS6 mRNAs, and miR-223 level in the synovial tissue were detected by qRT-PCR. Differences in miR-223 level and mRNA levels of mTOR, S6K, and RPS6 between the two groups were compared. The correlations between the level of miR-223 and the mRNA levels of mTOR, S6K, and RPS6, as well as anti-CCP antibody and disease activity indicators, were analyzed in the RA group.  Results  The miR-223 level in the RA group was significantly increased compared with the OA group (P < 0. 001), while the mRNA levels of S6K and RPS6 in the RA group were significantly decreased compared with the OA group (P < 0.05), There was no statistically significant difference in the expression level of mTOR mRNA between the RA group and the OA group. The miR-223 level in the RA group was negatively correlated with the mRNA levels of S6K and RPS6 (P < 0.05), but no significant correlation was found between miR-223 level and the level of mTOR mRNA. The levels of miR-223 and mTOR mRNA in the RA group were negatively correlated with the serum antiCCP antibody level (P < 0.05), while the level of RPS6 mRNA was positively correlated with the anti-CCP antibody level (P=0.009). The miR-223 level in the RA group was positively correlated with the serum CRP level (P=0.043), There was no correlation between the mRNA levels of RPS6, mTOR, and S6K and the CRP level.  Conclusion  An abnormal miR-223/ mTOR / S6K pathway exists in the synovial tissue of RA knee joints, correlating with the levels of anti-CCP antibody and CRP, indicating the potential pathways for further research into the pathogenesis of RA.

     

  • loading
  • [1]
    LIU S, MA H H, ZHANG H X, et al. Recent advances on signaling pathways and their inhibitors in rheumatoid arthritis[J]. Clin Immunol, 2021, 230: 108793. DOI: 10.1016/j.clim.2021.108793.
    [2]
    JIN Q B, REN F H, SONG P. Innovate therapeutic targets for autoimmune diseases: insights from proteome-wide mendelian randomization and Bayesian colocalization[J]. Autoimmunity, 2024, 57(1): 2330392. DOI: 10.1080/08916934.2024.2330392.
    [3]
    CHOY E H. Clinical significance of Janus kinase inhibitor selectivity[J]. Rheumatology (Oxford), 2019, 58(6): 953-962.
    [4]
    NEUMANN E, HECK C, MULLER-LADNER U. Recent developments in the synovial fibroblast pathobiology field in rheumatoid arthritis[J]. Curr Opin Rheumatol, 2024, 36(1): 69-75.
    [5]
    ZHENG Y, WEI K, JIANG P, et al. Macrophage polarization in rheumatoid arthritis: signaling pathways, metabolic reprogramming, and crosstalk with synovial fibroblasts[J]. Front Immunol, 2024, 15: 1394108. DOI: 10.3389/fimmu.2024.1394108.
    [6]
    PANWAR V, SⅡNGH A, BHATT M, et al. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease[J]. Signal Transduct Target Ther, 2023, 8(1): 375.
    [7]
    RAMASUBBU K, DEVI RAJESWARI V. Impairment of insulin signaling pathway PI3K/Akt/mTOR and insulin resistance induced AGEs on diabetes mellitus and neurodegenerative diseases: a perspective review[J]. Mol Cell Biochem, 2023, 478(6): 1307-1324.
    [8]
    QI H, YU M M, FAN X Q, ZHOU Y W, et al. Methionine and leucine promote mTOR gene transcription and milk synthesis in mammary epithelial cells through the eEF1Bα-UBR5-ARID1A signaling[J]. J Agric Food Chem, 2024, 72(20): 11733-11745.
    [9]
    BARKER B E, HANLON M M, MARZAIOLI V, et al. The mammalian target of rapamycin contributes to synovial fibroblast pathogenicity in rheumatoid arthritis[J]. Front Med (Lausanne), 2023, 10: 1029021. DOI: 10.3389/fmed.2023.1029021.
    [10]
    KITAYAMA K, KAWAMOTO T, KAWAKAMI Y, et al. Regulatory roles of miRNAs 16, 133a, and 223 on osteoclastic bone destruction caused by breast cancer metastasis[J]. Int J Oncol, 2021, 59(5): 97.
    [11]
    OTON-GONZALEZ L, MAZZIOTTA C, IAQUINTA M R, et al. Genetics and epigenetics of bone remodeling and metabolic bone diseases[J]. Int J Mol Sci, 2022, 23(3): 1500.
    [12]
    郑智琴, 施加才. 抗环瓜氨酸多肽抗体及类风湿因子联合检测用于类风湿关节炎的价值[J]. 中国临床医生杂志, 2022, 50(8): 923-925.

    ZHENG Z Q, SHI J C. The value of combined detection of anti-CCP antibody with rheumatoid factor in rheumatoid arthritis[J]. Chin J Clinician, 2022, 50(8): 923-925.
    [13]
    王涛, 李志军. 类风湿关节炎的诊断与治疗[J]. 中华全科医学, 2020, 18(2): 170-171. http://www.zhqkyx.net/article/id/db5b4b90-cd84-4faf-aea9-553bd1709ec4

    WANG T, LI Z J. The diagnosis and treatment of rheumatoid arthritis[J]. Chinese Journal of General Practice, 2020, 18(2): 170-171. http://www.zhqkyx.net/article/id/db5b4b90-cd84-4faf-aea9-553bd1709ec4
    [14]
    KIM K W, KIM B M, MOON H W, et al. Role of C-reactive protein in osteoclastogenesis in rheumatoid arthritis[J]. Arthritis Res Ther, 2015, 17(1): 41.
    [15]
    FANG Z, LYU J, WANG J, et al. C-reactive protein promotes the activation of fibroblast-like synoviocytes from patients with rheumatoid arthritis[J]. Front Immunol, 2020, 11: 958. DOI: 10.3389/fimmu.2020.00958.
    [16]
    SVANBERG C, ENOCSSON H, GOVENDER M, et al. Conformational state of C-reactive protein is critical for reducing immune complex-triggered type Ⅰ interferon response: implications for pathogenic mechanisms in autoimmune diseases imprinted by type Ⅰ interferon gene dysregulation[J]. J Autoimmun, 2023, 135: 102998. DOI: 10.1016/j.jaut.2023.102998.
    [17]
    RIZO-TÉLLEZ S A, SEKHERI M, FILEP J G. C-reactive protein: a target for therapy to reduce inflammation[J]. Front Immunol, 2023, 14: 1237729. DOI: 10.3389/fimmu.2023.1237729.
    [18]
    CHEN S Y, TSAI T C, LI Y T, et al. Interleukin-23 mediates osteoclastogenesis in collagen-induced arthritis by modulating microRNA-223[J]. Int J Mol Sci, 2022, 23(17): 9718. DOI: 10.3390/ijms23179718.
    [19]
    HUANG Y, LU D, MA W, et al. miR-223 in exosomes from bone marrow mesenchymal stem cells ameliorates rheumatoid arthritis via downregulation of NLRP3 expression in macrophages[J]. Mol Immunol, 2022, 143: 68-76.
    [20]
    LAPIC I, PADOAN A, BOZZATO D, et al. Erythrocyte sedimentation rate and C-reactive protein in acute inflammation[J]. Am J Clin Pathol, 2020, 153(1): 14-29.
    [21]
    SEBASTIANI G D, FULCI V, NICCOLINI S, et al. Overexpression of miR-223 in T-lymphocytes of early rheumatoid arthritis patients[J]. Clin Exp Rheumatol, 2011, 29(6): 1058-1059.
    [22]
    LU M C, YU C L, CHEN H C, et al. Increased miR-223 expression in T cells from patients with rheumatoid arthritis leads to decreased insulin-like growth factor-1-mediated interleukin-10 production[J]. Clin Exp Immunol, 2014, 177(3): 641-651.
    [23]
    WYMAN B, PERL A. Metabolic pathways mediate pathogenesis and offer targets for treatment in rheumatic diseases[J]. Curr Opin Rheumatol, 2020, 32(2): 184-191.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(2)

    Article Metrics

    Article views (12) PDF downloads(1) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return